DE2137045A1 - Arzneimittelzubereitung - Google Patents

Arzneimittelzubereitung

Info

Publication number
DE2137045A1
DE2137045A1 DE19712137045 DE2137045A DE2137045A1 DE 2137045 A1 DE2137045 A1 DE 2137045A1 DE 19712137045 DE19712137045 DE 19712137045 DE 2137045 A DE2137045 A DE 2137045A DE 2137045 A1 DE2137045 A1 DE 2137045A1
Authority
DE
Germany
Prior art keywords
thiazolyl
thiourea
methyl
compound
diethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712137045
Other languages
German (de)
English (en)
Inventor
Willy Dr. Reinach; Rheiner jun. Alfred Dr. Basel; Richie Rolf Dr. Möhlin; Burkard (Schweiz)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2137045A1 publication Critical patent/DE2137045A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE19712137045 1970-07-24 1971-07-23 Arzneimittelzubereitung Pending DE2137045A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1124070 1970-07-24

Publications (1)

Publication Number Publication Date
DE2137045A1 true DE2137045A1 (de) 1972-01-27

Family

ID=4371509

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712137045 Pending DE2137045A1 (de) 1970-07-24 1971-07-23 Arzneimittelzubereitung

Country Status (8)

Country Link
AU (1) AU3041671A (it)
BE (1) BE770403A (it)
DE (1) DE2137045A1 (it)
FR (1) FR2100948B1 (it)
GB (1) GB1330545A (it)
IL (1) IL37235A (it)
NL (1) NL7108189A (it)
ZA (1) ZA714076B (it)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540143A2 (en) * 1991-08-02 1993-05-05 Medivir Aktiebolag Compounds and methods for inhibition of HIV and related viruses
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540143A2 (en) * 1991-08-02 1993-05-05 Medivir Aktiebolag Compounds and methods for inhibition of HIV and related viruses
EP0540143A3 (it) * 1991-08-02 1995-01-04 Medivir Ab
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses
US5658907A (en) * 1991-08-02 1997-08-19 Medivir A/B Compounds and methods for inhibition of HIV and related viruses
US5714503A (en) * 1991-08-02 1998-02-03 Medivir Ab Compounds and methods for inhibition of HIV and related viruses

Also Published As

Publication number Publication date
ZA714076B (en) 1972-03-29
AU3041671A (en) 1973-01-04
FR2100948B1 (it) 1974-09-06
IL37235A0 (en) 1971-10-20
BE770403A (fr) 1972-01-24
FR2100948A1 (it) 1972-03-24
IL37235A (en) 1973-10-25
GB1330545A (en) 1973-09-19
NL7108189A (it) 1972-01-26

Similar Documents

Publication Publication Date Title
DE3688296T2 (de) Arzneimittel zur behandlung von erbrechen.
DE3514054C2 (it)
DE3874917T2 (de) Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
DE3586920T2 (de) Benzopyranverbindungen zur verwendung auf das kardiovaskulaere system.
DE2555411A1 (de) Pharmazeutische zusammensetzung mit einem n-substituierten pyridon
DE3786893T2 (de) Piperidinderivat zur Schmerzbehandlung.
DE2523998A1 (de) Pharmazeutische zubereitung fuer die behandlung der schizophrenie
DE2823174A1 (de) Arzneimittel fuer die prophylaktische behandlung postoperativer tiefer venenthrombose
DE69005978T2 (de) Verwendung von Actinonin zur Herstellung eines Medikamentes zur Inhibierung der Angiogenese.
DE3779842T2 (de) Antiallergisches mittel.
DE3419935A1 (de) Verwendung von hydroxyindolderivaten bei der senkung des blutdrucks
DE69115528T2 (de) Neue pharmazeutische Verwendungen von Forskolin-Derivaten
DE3916417A1 (de) Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid als aktive wirkstoffe
DE3445183A1 (de) Proglumide enthaltende arzneimittel mit analgetischer wirkung
DE2212840A1 (de) Mittel zur Behandlung kardiovaskulaerer Stoerungen und pharmazeutische Praeparate zu seiner Anwendung
DE2137045A1 (de) Arzneimittelzubereitung
DE69004529T2 (de) Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
DE2528460A1 (de) Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE60005526T2 (de) Verwendung von 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine zur behandlung von erkrankungen des magen-darm-traktes
DE69302250T2 (de) Verwendung von Isoquinolinon-Derivaten zur Behandlung von Hyperlipoproteinemia
DE4217396A1 (de) Metrifonat enthaltendes Arzneimittel
DE2501649C3 (de) Thiophen-2-carbonsäuresalz des Papaverins, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3816603A1 (de) Verwendung des thiazol-derivates tiprotimod zur herstellung eines mittels zur therapie von virusinfektionen
EP0281608A1 (de) Hydroxyindolderivat.
DE2823266A1 (de) Prophylaktisches oder therapeutisches mittel zur behandlung von allergieerkrankungen und verfahren zu seiner herstellung